Status:
COMPLETED
Alignment of PrEP Use With HIV Risk in Young Women and Men
Lead Sponsor:
University of Washington
Collaborating Sponsors:
Makerere University
MU-JHU CARE
Conditions:
Pre-Exposure Prophylaxis
Sexually Transmitted Diseases, Bacterial
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
Oral pre-exposure prophylaxis (PrEP) is a recommended component of combination HIV prevention and its availability is rising through demonstration projects and full-scale national programs. In sub-Sah...
Detailed Description
The proposed research will engage a new cohort of young men, whose female partners are already engaged in the Kampala Women's Bone Study. Women in the Kampala Women's Bone Study will be invited to eng...
Eligibility Criteria
Inclusion
- Men ages ≥18
- Has a female sexual partner enrolled in the Kampala Women's Bone Study
- Willing and able to provide informed consent
Exclusion
- Has any other condition that would preclude the ability to provide informed consent, make study participation unsafe, complicate the interpretation of study findings or otherwise interfere with achievement of the study objectives, in the investigator's discretion.
- Eligibility for women:
- Inclusion criteria:
- Participating in the Kampala Women's Bone Study
- Willing to talk with male sex partners about the new study for men and refer men for study recruitment
- Exclusion criteria:
- Has concerns about potential social harm stemming from anticipated conversations with male sex partners about the new study for men such that study staff would discourage the women from participation
- Investigator discretion
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2023
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT04664998
Start Date
May 1 2018
End Date
December 10 2023
Last Update
June 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Infectious Disease Institute
Kampala, Uganda